A pioneer in cosmetic dermatology, Kaya remains unchallenged in the organised skin clinic space in India. Management is confident of 20% revenue CAGR over the next 3-5 years, a claim that looks surpassable. A new found focus on product sales adds synergies to its story. Kaya turned profitable in FY14 (after 11 years of losses) and has significant untapped operating leverage in its operations.
The business model is unique and impregnable. Hardly any long term capital is required as…
Marico Kaya INITIATING COVERAGE Report By HDFC Sec
| Subscribe To Our Free Newsletter |
